Heart Attack Risk

Heart attack risk tests help you measure the biology that drives plaque buildup and instability. While blood tests can’t show blocked arteries directly, they reveal atherogenic particle burdengenetic lipoproteinslow-grade inflammationglucose control, and kidney health—all key to long-term risk.

A practical plan starts with a standard lipid panel and A1c/glucose, then adds ApoB (particle number), lipoprotein(a) [Lp(a)] (genetic risk), and hs-CRP (inflammation) to sharpen the picture. ... See more

  • Page
  • 1
  • of
  • 2
  • Total Rows
  • 48
Name Matches
Serum
Phlebotomist

Varied, Blood, Serum
Phlebotomist

Serum, Blood, Varied
Phlebotomist

Serum, Varied, Blood, Plasma-Unspecified Vial Pour
Phlebotomist

The ADMA and SDMA Test measures asymmetric and symmetric dimethylarginine, biomarkers of nitric oxide metabolism and endothelial function. Elevated levels are linked to cardiovascular disease, kidney dysfunction, and metabolic disorders. Doctors order this test to assess vascular health, kidney function, or cardiovascular risk. Results provide critical insight into endothelial damage, early detection of disease, and guidance for preventive or therapeutic strategies.

Serum
Phlebotomist
Also Known As: ADMA/SDMA Test

The Apolipoprotein A1 (Apo A1) Test measures levels of Apo A1, the main protein in HDL cholesterol, to assess heart and vascular health. Higher levels are linked to protective “good” cholesterol, while low levels may increase risk of heart disease, stroke, or metabolic disorders. Doctors use this test with lipid panels to evaluate cardiovascular risk, monitor therapy, and guide prevention strategies for cholesterol balance and heart health.

Serum
Phlebotomist
Also Known As: Apo A1 Test, Apolipoprotein A-1 Test

The Apolipoprotein A1 and B Test measures Apo A1, the main protein in HDL cholesterol, and Apo B, the primary protein in LDL and VLDL cholesterol. Together, these markers and the ApoB/A1 ratio provide a clearer picture of cardiovascular risk than standard lipid panels. High ApoB or low Apo A1 may signal heart disease, stroke, or atherosclerosis. Doctors use this test to evaluate cholesterol balance, monitor therapy, and guide prevention of cardiovascular conditions.

Serum
Phlebotomist
Also Known As: Apo A1 and B Test, Apolipoprotein Evaluation Test

The Apolipoprotein B (ApoB) Test measures ApoB, the main protein in LDL and VLDL cholesterol, to assess cardiovascular risk. Elevated ApoB is linked to atherosclerosis, coronary artery disease, heart attack, and stroke. Low levels may reflect liver disease or malnutrition. Doctors often order this test with lipid panels or Apo A1 to calculate the ApoB/A1 ratio, providing a more accurate picture of cholesterol balance, cardiovascular health, and risk for heart disease.

Serum
Phlebotomist
Also Known As: Apo B Test, Apolipoprotein B-100 Test

Most Popular

The High-Sensitivity C-Reactive Protein (hs-CRP) Test measures very low levels of CRP in blood to evaluate inflammation and cardiovascular risk. Elevated hs-CRP may indicate increased risk for heart disease, heart attack, or stroke even before symptoms appear. Doctors use this test along with cholesterol and other markers to assess overall heart health, guide prevention strategies, and monitor treatment. It also helps evaluate chronic inflammation and metabolic conditions.

Serum
Phlebotomist
Also Known As: Cardiac CRP Test, High Sensitivity C-Reactive Protein Test

The Cardio IQ™ ApoE Genotype Test analyzes apolipoprotein E (ApoE) gene variants linked to cholesterol metabolism and cardiovascular risk. Results help assess risk for heart disease, hyperlipidemia, and Alzheimer’s disease. This genetic test guides personalized prevention and treatment strategies, including diet, lifestyle, and lipid-lowering therapies, supporting long-term cardiovascular and brain health.

Blood
Phlebotomist
Also Known As: ApoE Cardiac Risk Test, ApoE Cardiovascular Disease Test, Apolipoprotein E Test, Apo E Test, ApoE Protein Test

The Cardio IQ™ KIF6 Genotype Test analyzes genetic variation in the KIF6 gene, associated with cardiovascular disease and coronary heart disease risk. Research suggests certain variants may influence lipid metabolism, vascular inflammation, and response to statin therapy. This test provides insight into inherited cardiovascular risk factors and supports personalized approaches to prevention and treatment strategies.

Blood
Phlebotomist

The Cardio IQ™ Lipoprotein Fractionation Ion Mobility Test separates and measures lipoprotein particles by size and concentration using ion mobility technology. It provides a detailed profile of LDL, HDL, and other subclasses, offering a clearer assessment of cardiovascular risk than standard cholesterol testing.

Serum
Phlebotomist
Also Known As: LDL Particle Testing, LDL Subclass Test, LDL Fractionations Test

The NMR Lipoprotein Fractionation Test uses nuclear magnetic resonance to measure particle size and concentration of LDL, HDL, and VLDL cholesterol. Unlike a standard lipid panel, it provides detailed information on lipoprotein subfractions linked to cardiovascular risk. Doctors use this test to assess heart disease risk, guide cholesterol management, and monitor therapy effectiveness. It offers deeper insight into lipid metabolism and cardiovascular health.

Serum
Phlebotomist
Also Known As: NMR Test, LDL Particle Testing, LDL Subclass Test, LDL Fractionations Test

The Cardio IQ™ Lp-PLA2 PLAC® Test measures lipoprotein-associated phospholipase A2, an enzyme linked to vascular inflammation and plaque instability. Elevated levels are associated with increased risk of coronary heart disease and ischemic stroke. Doctors use this blood test to assess cardiovascular risk beyond standard cholesterol testing, helping guide prevention and treatment strategies to reduce risk of heart attack or stroke.

Also Known As: LpPLA2 Test, Ps-PLA2 Activity Test, Lipoprotein-Associated Phospholipase A2 Test

The Cardio IQ™ Triglycerides Test measures triglyceride levels in the blood, an important marker of lipid metabolism and cardiovascular health. Elevated triglycerides are linked to increased risk of heart disease, pancreatitis, and metabolic syndrome. Physicians use this test to assess risk factors, monitor therapy response, and guide lifestyle or treatment decisions, often as part of a broader lipid or heart health evaluation.

Serum
Phlebotomist

The Complete Blood Count with Differential and Platelets Test is a comprehensive blood test that checks red blood cells, white blood cells, hemoglobin, hematocrit, and platelets. The differential analyzes types of white blood cells to detect infections, anemia, clotting abnormalities, immune conditions, and certain cancers. This essential test is often ordered for routine health exams, diagnosis, and monitoring treatment progress.

Blood
Phlebotomist
Also Known As: CBC Test, CBC with Differential and Platelets Test, CBC w/Diff and Platelets Test, Full Blood Count Test, Complete Blood Count Test

The Comprehensive Metabolic Panel (CMP) Test measures 21 markers to assess metabolic health, liver and kidney function, and electrolyte balance. It includes glucose, calcium, sodium, potassium, chloride, CO2, albumin, globulin, A/G ratio, total protein, bilirubin, ALP, AST, ALT, BUN, creatinine, BUN/creatinine ratio, and eGFR. The CMP helps detect diabetes, liver or kidney disease, and supports routine screening and chronic condition monitoring.

Serum
Phlebotomist
Also Known As: CMP Test, Chemistry Panel Test, Chem Test, Chem 21 Test, Chem 14 Test 

The Creatine Kinase (CK) Total Test measures CK enzyme levels in blood to detect muscle injury, inflammation, or stress. Elevated CK may indicate muscle disorders, heart attack, strenuous exercise, or conditions such as rhabdomyolysis, while low levels are less common. Doctors use this test to evaluate unexplained muscle pain, weakness, or chest pain and to monitor recovery. It provides insight into muscle, cardiac, and overall metabolic health.

Serum
Phlebotomist
Also Known As: CK Total Test, Creatine Phosphokinase, CPK Test

The Creatine Kinase (CK) Isoenzymes with Total CK Panel measures overall CK levels and breaks them into isoenzymes (CK-MM, CK-MB, CK-BB) to identify muscle, heart, or brain injury. Elevated CK-MB may suggest a heart attack, while CK-MM points to skeletal muscle damage, and CK-BB indicates brain injury. Doctors order this test for chest pain, muscle weakness, or trauma. Results provide critical insight for diagnosing and monitoring tissue damage.

Also Known As: CPK Isoenzymes Test

The Cystatin C Test with eGFR measures blood levels of cystatin C, a protein filtered by the kidneys, and calculates estimated glomerular filtration rate (eGFR). This test provides a sensitive marker for kidney function and can detect early kidney disease, even when creatinine levels are normal. Doctors order it to evaluate chronic kidney disease risk, monitor treatment, and assess overall kidney health in patients with diabetes, hypertension, or other conditions.

Serum
Phlebotomist
Also Known As: CysX Test, CysC Test

The Fibrinogen Activity Test measures how well fibrinogen, a key clotting protein, helps blood form clots. Low fibrinogen may indicate excessive bleeding, liver disease, or disseminated intravascular coagulation (DIC), while high levels may signal inflammation or increased clotting risk. Doctors use this test to evaluate unexplained bleeding, monitor clotting disorders, or assess liver function. Results provide vital insight into coagulation health and treatment management.

Varied
Phlebotomist
Also Known As: Factor 1 Assay Test, Cardiac Fibrinogen Test, Clotting Factors Test

The Galectin-3 Test measures levels of galectin-3, a biomarker linked to heart failure, cardiac fibrosis, and inflammation. Elevated results may indicate worsening heart disease, increased risk of hospitalization, or progression of chronic conditions. Doctors use this blood test to assess heart health, guide treatment decisions, and monitor patients with heart failure, offering valuable insight into long-term cardiovascular risk and management.

Plasma-Unspecified Vial Pour
Phlebotomist

Most Popular

The GGT Test measures gamma-glutamyl transferase, an enzyme found in the liver and bile ducts, to evaluate liver health. Elevated GGT may indicate liver disease, bile duct obstruction, alcohol use, or medication side effects. Doctors order this test to investigate symptoms like fatigue, jaundice, dark urine, or abdominal pain and to monitor liver damage. It is often performed with other liver tests to provide a complete picture of liver and bile duct function.

Serum
Phlebotomist
Also Known As: Gamma Glutamyl Transferase Test, Gamma Glutamyl TransPeptidase Test, GGTP Test, GTP Test

Most Popular

The Homocysteine Test measures homocysteine levels in blood to assess risk for heart disease, stroke, and vascular problems. Elevated homocysteine may result from vitamin B6, B12, or folate deficiency and is linked to blood clots, cognitive decline, and osteoporosis. Doctors use this test to evaluate cardiovascular risk, monitor nutritional deficiencies, and guide treatment for metabolic or genetic conditions affecting homocysteine metabolism.

Serum
Phlebotomist
Also Known As: Homocysteine Cardiac Risk Test

Most Popular

The Lipid Panel Test checks six key blood lipids: total cholesterol, HDL cholesterol, LDL cholesterol, non-HDL cholesterol, triglycerides, and the Chol/HDL ratio. This panel assesses risk for cardiovascular disease, heart attack, and stroke by evaluating cholesterol balance and fat levels in the blood. Doctors use lipid panel results for routine screening, treatment monitoring, and guiding lifestyle or medication adjustments.

Also Known As:  Lipid Profile Test, Cholesterol Panel Test, Lipids Blood Test 

Also referred to as an acute myocardial infarct, a heart attack occurs when an artery blockage prevents blood from flowing to a portion of a person’s heart. Heart tissue can be damaged or even destroyed if someone isn’t treated swiftly. A heart attack can be fatal. The American Heart Association states that approximately 735,000 people in the United States experience heart attacks each year. Around 120,000 of those people do not survive.  

The symptoms and signs linked with insufficient blood flowing to the heart are referred to as Acute coronary syndrome (ACS). What separates a heart attack from other types of ACS is that the decrease in blood flows continues, which causes heart muscle cells to be damaged or destroyed. If someone is brought into the ER, healthcare workers need to run tests to see if the symptoms are caused by a heart attack or something else.  

The human heart is an organ that’s primarily made from cardiac muscle. It uses a system ... See more